We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.
- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved - On Track to Regain Compliance with All Nasdaq Listing Requirements - No Variable Priced Securities are...
- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and Warrant Conversions were Investor Initiated...
- Stockholders’ equity significantly surpasses the $2.5 million minimum required by Nasdaq - Company is to seek Nasdaq’s formal confirmation of compliance with equity requirements under the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0941 | -12.0641025641 | 0.78 | 0.849 | 0.643 | 5872552 | 0.76358875 | CS |
4 | -0.8141 | -54.2733333333 | 1.5 | 3.46 | 0.643 | 8498205 | 1.06664627 | CS |
12 | -7.3141 | -91.42625 | 8 | 8.8 | 0.643 | 3697323 | 1.5696833 | CS |
26 | -9.6141 | -93.340776699 | 10.3 | 22.2 | 0.643 | 2510830 | 4.45891573 | CS |
52 | -12319.3141 | -99.9944326299 | 12320 | 12636.8 | 0.643 | 1737726 | 982.87288239 | CS |
156 | 2220701.35715 | -100.000030887 | -2220700.67125 | 123520 | -1484398.55187 | 1560583 | -18607.9601493 | CS |
260 | 2220701.35715 | -100.000030887 | -2220700.67125 | 123520 | -1484398.55187 | 1560583 | -18607.9601493 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions